What ACCELERON PHARMA INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Mclaughlin Kevin F | SVP, CFO and Treasurer | Nov 19 | Tender Offer · U | −10,681 | — | — | 0 |
| Kango Sujay | EVP, Chief Commercial Officer | Nov 19 | Tender Offer · U | −18,509 | — | — | 0 |
| Veness Adam M | SVP, General Counsel and Sec. | Nov 19 | Tender Offer · U | −23,423 | — | — | 0 |
| Nader Francois | Director | Nov 19 | Tender Offer · U | −6,749 | — | — | 0 |
| Hamill Laura | Director | Nov 19 | Tender Offer · U | −474 | — | — | 0 |
| Smith Karen L. | Director | Nov 19 | Tender Offer · U | −1,622 | — | — | 0 |
| Zakrzewski Joseph S | Director | Nov 19 | Tender Offer · U | −34,499 | — | — | 0 |
| Dable Habib J | CEO and President | Nov 19 | Tender Offer · U | −98,450 | — | — | 0 |
| Backstrom Jay T. | EVP, Research and Development | Nov 19 | Tender Offer · U | −21,233 | — | — | 0 |
| Hite Christopher | Director | Nov 19 | Tender Offer · U | −930 | — | — | 0 |
| Mccourt Thomas A | Director | Nov 19 | Tender Offer · U | −6,044 | — | — | 0 |
| Kearney Terrence C | Director | Nov 19 | Tender Offer · U | −6,749 | — | — | 0 |
| Malik Kemal | Director | Nov 19 | Tender Offer · U | −1,622 | — | — | 0 |
| Veness Adam M | SVP, General Counsel and Sec. | Nov 09 | Exercise / conversion · M | +4,500 | $29.37 | +$132K | 23,423 |
| Kango Sujay | EVP, Chief Commercial Officer | Sep 27 | Open-market sale · S | −5,000 | $175.00 | −$875K | 18,509 |
| Kango Sujay | EVP, Chief Commercial Officer | Sep 27 | Exercise / conversion · M | +5,000 | $40.61 | +$203K | 23,509 |
| Mclaughlin Kevin F | SVP, CFO and Treasurer | Sep 24 | Open-market sale · S | −5,370 | $160.38 | −$861K | 10,681 |
| Mclaughlin Kevin F | SVP, CFO and Treasurer | Sep 24 | Exercise / conversion · M | +170 | $41.64 | +$7.08K | 16,051 |
| Mclaughlin Kevin F | SVP, CFO and Treasurer | Sep 24 | Exercise / conversion · M | +5,200 | $40.61 | +$211K | 15,881 |
| Mclaughlin Kevin F | SVP, CFO and Treasurer | Sep 23 | Open-market sale · S | −983 | $161.26 | −$159K | 10,681 |
Loading...
